May 21, 07:05 PM

Jeff Bezos-Backed Altos Labs Acquires Dorian Therapeutics, NewLimit Raises $130M for Anti-Aging Therapies

Altos Labs, a biotechnology company backed by $3 billion in funding from Jeff Bezos and other investors, has acquired Dorian Therapeutics, a Peninsula-based firm specializing in senoblockers, expanding its pipeline focused on anti-aging therapies. Meanwhile, NewLimit, another biotech startup, has raised $130 million to develop treatments aimed at reversing aging in human cells, with three therapies currently in development targeting the restoration of liver cell function. Additionally, Spanish researchers have identified mechanisms of blood aging, which could pave the way for anti-aging interventions in humans following successful trials in mice.

#Altos Labs #Jeff Bezos #Dorian Therapeutics #NewLimit #Spanish

Written with ChatGPT (GPT-4).

Sources

San Francisco Business Times@SFBusinessTimes
1 year ago
Altos Labs, backed by $3 billion from Jeff Bezos and others, has snagged a small Peninsula company focused on one approach to stopping aging https://t.co/TynvEMFkCH
Ron Leuty@rleuty_biotech
1 year ago
Forever young: Bezos-backed Altos Labs snags early-stage Peninsula anti-aging company https://t.co/gpR7JfRW9U via @SFBusinessTimes
20minutos.es@20m
1 year ago
Una investigación española descubre cómo envejece la sangre y abre la puerta a métodos para revertirlo https://t.co/NJf2b5hBBX ➡ Después de probarlo en ratones, se podrían realizar métodos antienvejecimiento en humanos

Jeff Bezos-Backed Altos Labs Acquires Dorian Therapeutics, NewLimit Raises $130M for Anti-Aging Therapies

Sources

Additional media